Related Experiment Videos
A teaching tool for patients receiving continuous i.v. infusion recombinant interleukin-2 therapy
E Sharp1, C DePriest, L A Potts
1Williamson Medical Center, Franklin, TN.
Oncology Nursing Forum
|June 1, 1994
Summary
A new educational tool helps patients and families understand continuous intravenous interleukin-2 (IL-2) therapy, covering its development, side effects, and management. This resource was well-received by all users and improves nursing efficiency.
Area of Science:
- Oncology Nursing
- Immunotherapy Education
- Patient Adherence
Background:
- Continuous intravenous (IV) therapy with interleukin-2 (IL-2) requires comprehensive patient and family education.
- Effective patient education is crucial for managing side effects and ensuring treatment adherence.
- Existing educational materials may not adequately address the complexities of IL-2 therapy.
Purpose of the Study:
- To present a novel educational tool designed for patients and families receiving continuous IV interleukin-2 (IL-2) therapy.
- To provide a standardized and accessible resource for understanding IL-2 treatment.
Main Methods:
- Development of a patient education tool based on published literature and clinical expertise.
- Content review by patients, families, and healthcare providers.
Main Results:
- The educational tool covers IL-2 development, immune function, common side effects, management strategies, and emergency contact information.
- The material received positive feedback from patients, families, and healthcare providers.
Conclusions:
- The developed patient education tool is effective in enhancing understanding of IL-2 therapy.
- Utilizing this written tool improves the efficiency of nursing time in patient education.
- This resource supports nurses in effectively teaching patients about continuous IV IL-2 therapy.